Acepodia 与 Pfizer Ignite 合作，扩大自身免疫性疾病的 ACC 疗法。 Acepodia partners with Pfizer Ignite to expand ACC therapies for autoimmune diseases.

Acepodia 是一家临床阶段的生物技术公司，已与 Pfizer Ignite 合作，以增强其针对自身免疫性疾病的抗体-细胞偶联 （ACC） 疗法。 Acepodia, a clinical-stage biotechnology firm, has partnered with Pfizer Ignite to enhance its Antibody-Cell Conjugation (ACC) therapies for autoimmune diseases. 此次合作将为 Acepodia 提供战略支持和资源，使其能够将应用扩展到癌症治疗之外。 This collaboration will provide Acepodia with strategic support and resources, enabling it to expand its applications beyond cancer treatments.